ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prognostic value of final pathological stage in colon adenocarcinoma after neoadjuvant chemotherapy: A propensity score-matched study

Xiang, Meijuan; Liang, Zongyu; Gao, Yuan; Feng, Xingyu*; Yao, Xueqing*广东省人民医院; 南方医科大学; 6; 5
Frontiers in Surgery2022-10-26DOI: 10.3389/fsurg.2022.1022025
1被引4阅读
引用收藏
分享

摘要

BackgroundNeoadjuvant chemotherapy (NAC) could improve local tumor control of locally advanced colon cancer (LACC), but the prognostic value of yp stage in colon cancer remains unknown. Here, we aimed to ascertain yp stage as an indicator for LACC prognosis after NAC. MethodsThe data of patients diagnosed with colon adenocarcinoma between 2004 and 2015 were extracted from the Surveillance, Epidemiology, and End Results database. After 1:2 propensity score matching, cancer-specific survival (CSS) and overall survival (OS) were compared between the NAC and Non-NAC groups of different stage classifications. The correlation between clinical and pathological factors and CSS was identified. ResultsA total of 49, 149, and 81 matched pairs of stage 0-I, II, and III patients, respectively, were generated for analysis. For stage 0-I (p = 0.011) and III (p = 0.015), only CSS in the NAC groups were inferior. Receiving NAC was an independent prognostic risk factor for patients with stage 0-I (hazard ratio, 7.70; 95% confidence interval, 1.820-32.5; p = 0.006) and stage III (hazard ratio, 1.73; 95% confidence interval, 1.11-2.68; p = 0.015). ConclusionsThe CSS was poorer among LACC patients who underwent NAC than among those who did not. The yp stage of colon cancer after NAC has distinctive significance, which may contribute to predicting the prognosis and guiding the treatment of LACC patients after NAC.

学科与关键词

关键词
prognostic valueneoadjuvant chemotherapycolon canceryp stagesurvival
相关
加载中…
  • Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: a retrospective cohort study
    Lv, Zhihao*; Liang, Yuqi; Liu, Huaxi; Mo, DelongBMC CANCER, 2021, 21(1): 306.被引 10
  • The role of neoadjuvant chemotherapy in patients with locally advanced colon cancer: A systematic review and meta-analysis
    Liang, Zongyu*; Li, Zhu; Yang, Qingshui; Feng, Jiahao; Xiang, Deyu; Lyu, Haina; Mai, Guangzhi; Wang, Wanchuan*Frontiers in Oncology, 2022, 12: 1024345.被引 1
  • Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis
    Zhou, Huabin; Wang, Songsheng; Cai, Zhai; Qiu, Enming; Chen, Qianyun; Rao, Xi; Han, Shuai; Li, Zhou*INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37(12): 2481-2489.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Surgery
发表日期
2022-10-26
卷期
第 9 卷
页码
1022025
DOI
10.3389/fsurg.2022.1022025
期刊等级
3区
成果收录
SCIE

作者

  • X

    Xiang, Meijuan (第一作者)

    guangdong prov peoples hosp

  • L

    Liang, Zongyu

    2 · 6

查看全部 5 位作者收起作者
  • G

    Gao, Yuan

    2 · southern med univ

  • F

    Feng, Xingyu (通讯)

    guangdong prov peoples hosp

  • Y

    Yao, Xueqing (通讯)

    5 · gannan med univ · guangdong prov peoples hosp · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417